Lundbeck
HLUN-B.CO
#2346
Rank
A$9.80 B
Marketcap
$10.13
Share price
0.98%
Change (1 day)
21.37%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Lundbeck (HLUN-B.CO) - Total assets

Total assets on the balance sheet as of June 2024 : A$8.43 B

According to Lundbeck 's latest financial reports the company's total assets are A$8.43 B. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Lundbeck - Total assets on balance sheet (from 2009 to 2024)

Total assets by year

Year Total assets Change
2023-12-31A$8.13 B2.6%
2022-12-31A$7.92 B9.23%
2021-12-31A$7.25 B-6.12%
2020-12-31A$7.72 B-4.97%
2019-12-31A$8.13 B62.58%
2018-12-31A$5.00 B22.63%
2017-12-31A$4.07 B2.77%
2016-12-31A$3.96 B-7.47%
2015-12-31A$4.29 B-15.98%
2014-12-31A$5.10 B4.02%
2013-12-31A$4.90 B33.11%
2012-12-31A$3.68 B5.7%
2011-12-31A$3.48 B9.92%
2010-12-31A$3.17 B-13.96%
2009-12-31A$3.68 B8.32%
2008-12-31A$3.40 B23.37%
2007-12-31A$2.76 B5.52%
2006-12-31A$2.61 B3.97%
2005-12-31A$2.51 B-7.06%
2004-12-31A$2.70 B